Citation Impact
Citing Papers
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
2001 StandoutScienceNobel
A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
2001 StandoutScience
Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion
2008
Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury
2009
Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors
2001
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo
2005
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation
2001 StandoutNobel
Preconditioning: a paradigm shift in the biology of myocardial ischemia
2006
Protective responses in the ischemic myocardium
2000
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Shared Principles in NF-κB Signaling
2008 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Hypoxia and Inflammation
2011 Standout
Endothelial protective effects of preconditioning
2002
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
HIF-1, O2, and the 3 PHDs
2001 StandoutNobel
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
2003
Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
2011 StandoutNobel
Coxibs and Cardiovascular Disease
2004 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Lipid mediator class switching during acute inflammation: signals in resolution
2001
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Remote ischemic preconditioning confers late protection against myocardial ischemia–reperfusion injury in mice by upregulating interleukin-10
2012
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart
2006
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
2001 StandoutNobel
Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family
2002 StandoutNobel
Adenosine, an endogenous distress signal, modulates tissue damage and repair
2007
Myocardial Reperfusion Injury
2007 Standout
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
2008
Nonsteroidal Anti-Inflammatory drugs and cardiovascular risk
2004
Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1α
2003 StandoutNobel
Reactive oxygen species in cardiovascular disease
2011
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Dissection of the NF-κB signalling cascade in transgenic and knockout mice
2006
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
2001
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Genetic and pharmacological analysis of prostanoid receptor function
2001
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation
2001 StandoutNobel
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
2001 StandoutNobel
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program
2003
Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
2009
Role of the JAK–STAT pathway in myocardial injury
2006
Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models
2006
Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure
2010
NF-κB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning
2010
Therapeutic Manipulation of the HIF Hydroxylases
2009
Resolvin E1 protects the rat heart against reperfusion injury
2010
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP
2002 StandoutNobel
Genetic and pharmacological analysis of prostanoid receptor function
2001
Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain
2001 StandoutNobel
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling
2013
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
PROLINE HYDROXYLATION AND GENE EXPRESSION
2005 StandoutNobel
RvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis
2005
Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and Erythropoietin
2005
The Late Phase of Preconditioning
2000
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia
2002
Targeted deletion of NF-κB p50 diminishes the cardioprotection of histone deacetylase inhibition
2010
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
2002 StandoutScienceNobel
Targeting tumors through the HIF system
2000 StandoutNobel
Myocardial Protection at a Crossroads
2004
Cellular and Molecular Dissection of Reperfusion Injury
2000 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury
2004 StandoutNobel
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction
2007
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Resolvins
2002
The risk of cardiovascular thrombotic events with selective cyclooxygenase‐2 inhibitors
2002
Works of Yu-Ting Xuan being referenced
Role of the JAK–STAT Pathway in Protection Against Myocardial Ischemia/Reperfusion Injury
2003
Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α
2001
Bifunctional Role of Protein Tyrosine Kinases in Late Preconditioning Against Myocardial Stunning in Conscious Rabbits
1999
Nuclear Factor-κB Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits
1999
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits
2000
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits
2000
Role of the Protein Kinase C-ε–Raf-1–MEK-1/2–p44/42 MAPK Signaling Cascade in the Activation of Signal Transducers and Activators of Transcription 1 and 3 and Induction of Cyclooxygenase-2 After Ischemic Preconditioning
2005
Cardiac Myocyte–Specific Expression of Inducible Nitric Oxide Synthase Protects Against Ischemia/Reperfusion Injury by Preventing Mitochondrial Permeability Transition
2008
Endothelial Nitric Oxide Synthase Plays an Obligatory Role in the Late Phase of Ischemic Preconditioning by Activating the Protein Kinase Cε–p44/42 Mitogen-Activated Protein Kinase–pSer-Signal Transducers and Activators of Transcription1/3 Pathway
2007
Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3receptors
2001
Hypercholesterolemia Abrogates Late Preconditioning via a Tetrahydrobiopterin-Dependent Mechanism in Conscious Rabbits
2005
Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase-2–Dependent Mechanism
2003
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
1999
Delayed Adaptation of the Heart to Stress
2004